ATE45961T1 - Humanes cytomegalovirus immunserumglobulin mit hohem titer und verfahren zu seiner herstellung. - Google Patents

Humanes cytomegalovirus immunserumglobulin mit hohem titer und verfahren zu seiner herstellung.

Info

Publication number
ATE45961T1
ATE45961T1 AT84106456T AT84106456T ATE45961T1 AT E45961 T1 ATE45961 T1 AT E45961T1 AT 84106456 T AT84106456 T AT 84106456T AT 84106456 T AT84106456 T AT 84106456T AT E45961 T1 ATE45961 T1 AT E45961T1
Authority
AT
Austria
Prior art keywords
globulin
cytomegalovirus
sum
production
methods
Prior art date
Application number
AT84106456T
Other languages
English (en)
Inventor
Milton B Dobkin
Robert E Louie
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24004864&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE45961(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Miles Inc filed Critical Miles Inc
Application granted granted Critical
Publication of ATE45961T1 publication Critical patent/ATE45961T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/088—Varicella-zoster virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/089—Cytomegalovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT84106456T 1983-06-14 1984-06-06 Humanes cytomegalovirus immunserumglobulin mit hohem titer und verfahren zu seiner herstellung. ATE45961T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/504,105 US4617379A (en) 1983-06-14 1983-06-14 High titer cytomegalovirus immune serum globulin
EP84106456A EP0128522B1 (de) 1983-06-14 1984-06-06 Humanes Cytomegalovirus Immunserumglobulin mit hohem Titer und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
ATE45961T1 true ATE45961T1 (de) 1989-09-15

Family

ID=24004864

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84106456T ATE45961T1 (de) 1983-06-14 1984-06-06 Humanes cytomegalovirus immunserumglobulin mit hohem titer und verfahren zu seiner herstellung.

Country Status (6)

Country Link
US (1) US4617379A (de)
EP (1) EP0128522B1 (de)
JP (1) JPH0625070B2 (de)
AT (1) ATE45961T1 (de)
CA (1) CA1244767A (de)
DE (1) DE3479583D1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808518A (en) * 1985-02-11 1989-02-28 University Of Tennessee Research Corporation Recovery of cytomegalovirus antigen and use thereof in an assay
US4665159A (en) * 1985-11-07 1987-05-12 Miles Laboratories, Inc. High titer varicella-zoster immune globulin for intravenous administration
US4717564A (en) * 1985-11-07 1988-01-05 Miles Laboratories, Inc. High titer varicella-zoster immune globulin for intravenous administration
US4717766A (en) * 1986-01-27 1988-01-05 Miles Laboratories, Inc. Method of preparing high titer anti-respiratory syncytial virus intravenous immune globulin
US4659563A (en) * 1986-01-27 1987-04-21 Miles Laboratories, Inc. High titer anti-respiratory syncytial virus intravenous immune globulin
US4863730A (en) * 1986-03-21 1989-09-05 Cenfold Holdings, S.A. Immunotherapy for AIDS patients
AU668092B2 (en) * 1991-04-22 1996-04-26 Massachusetts Health Research Institute, Inc. Process of screening plasma samples for effective antibody titers against respiratory viruses
NO20014256D0 (no) * 2001-09-03 2001-09-03 Bjoern Kristiansen Fremstilling av immunstimulerende forbindelse
US6984492B2 (en) * 2003-09-05 2006-01-10 Talecris Biotherapeutics, Inc. Methods and compositions for treating herpes infections
US7514085B2 (en) * 2004-07-16 2009-04-07 Medimush A/S Immune modulating compounds from fungi
MX2007014219A (es) * 2005-05-13 2008-04-08 Medimush As Productos alimenticios o forrajeros que comprenden material fungico.
EP1896600A2 (de) * 2005-06-15 2008-03-12 Medimush A/S Gegen krebs gerichtete kombinationsbehandlung und kit
EP1896601A1 (de) * 2005-06-15 2008-03-12 Medimush A/S Mittels einer basidiomyzeten-immersionszellkultur produzierte biologische wirkstoffe
US8354249B2 (en) * 2005-08-11 2013-01-15 Omrix Biopharmaceuticals Ltd. Intravenous immunoglobulin composition
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
WO2009005870A2 (en) * 2007-04-12 2009-01-08 Omrix Biopharmaceuticals Ltd, Products for prophylaxis and/or treatment of viral diseases and method of making and using same
UA106354C2 (ru) 2008-07-16 2014-08-26 Инститьют Фо Рисерч Ин Байомедсин Антитела, нейтрализующие цитомегаловирус человека, и их применение
WO2013023362A1 (zh) * 2011-08-16 2013-02-21 深圳市卫武光明生物制品有限公司 静注巨细胞病毒人免疫球蛋白及其制备方法
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
AU2018213378A1 (en) * 2017-01-27 2019-08-01 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Vaccine compositions of herpesvirus envelope protein combinations to induce immune response
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903262A (en) * 1972-03-13 1975-09-02 Cutter Lab Pharmaceutical compositions comprising intravenously injectable modified serum globulin, its production and use
DE2610854A1 (de) * 1976-03-15 1977-09-22 Biotest Serum Institut Gmbh Galenische immunglobulinzubereitung
US4165370A (en) * 1976-05-21 1979-08-21 Coval M L Injectable gamma globulin
US4174388A (en) * 1977-02-14 1979-11-13 Merck & Co., Inc. Method for preparing hepatitis B immune globulin
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
US4186192A (en) * 1978-12-18 1980-01-29 Cutter Laboratories, Inc. Stabilized immune serum globulin
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
US4371520A (en) * 1981-10-28 1983-02-01 The Green Cross Corporation Process for preparing immunoglobulin suitable for intravenous injection

Also Published As

Publication number Publication date
DE3479583D1 (en) 1989-10-05
EP0128522B1 (de) 1989-08-30
EP0128522A3 (en) 1986-11-26
US4617379A (en) 1986-10-14
CA1244767A (en) 1988-11-15
JPH0625070B2 (ja) 1994-04-06
JPS6069032A (ja) 1985-04-19
EP0128522A2 (de) 1984-12-19

Similar Documents

Publication Publication Date Title
ATE45961T1 (de) Humanes cytomegalovirus immunserumglobulin mit hohem titer und verfahren zu seiner herstellung.
ATE49219T1 (de) Pseudomonas immunserumglobulin mit hohem titer und verfahren zu seiner herstellung.
NO20002413D0 (no) Antistoffer mot Moraxella proteiner og anvendelse derav, samt sett for pÕvisning av antigen og farmasøytisk preparat som inneholder antistoffer
DK0726758T3 (da) Peptider til inducering af cytotoksiske T-lymfocytreaktioner over for hepaptitis B virus
EP0687182A4 (de) Peptide zum induzieren einer antwort der zytotoxischen t-lymphozyten gerichtet gegen das hepatitis b virus
ATE166230T1 (de) Verwendung von anti-icam antikörpern zur herstellung eines präparats für die behandlung von endotoxinschock
OA09889A (en) Peptides for inducing-cytotoxic T-lymphocyte responses to hepatitis B virus.
ATA118995A (de) Humanes virussicheres monomeres immunglobulin a und verfahren zu seiner herstellung
ATA171686A (de) Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen
WO2002057314A3 (en) Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes
WO2004005316A3 (en) Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes
DE3750886D1 (de) Verwendung eines immunglobulinhaltigen Präparates zur Prophylaxe und Therapie von AIDS beim Menschen.
ATE122100T1 (de) Humaner monoklonaler antikörper und diesen enthaltende arzneimittelzusammensetzung zur behandlung von pseudomonasinfektionen.
DE69025629D1 (de) Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids-verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern
Day et al. Basophil-sensitizing antibody response to herpes simplex viruses in rabbits
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
Gordon Intravenous immunoglobulin: Historical perspective
DE520834T1 (de) PP14 oder Antikörper gegen PP14 enthaltende pharmazeutische Zusammensetzung zur Behandlung von Immunsystemstörungen.
Odendaal et al. The passive protection of lambs against Clostridium perfringens type D with semi-purified hyperimmune serum
DE3679255D1 (de) Behandlung chronischer entzuendungskrankheiten.
DE68913932T2 (de) Arzneimittel für die Behandlung oder die Verhütung von Infektionen mit HIV durch Immunisierung, und Verfahren zur Herstellung.
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
Mozen HIV inactivation in plasma products
ATE126704T1 (de) Bcrf1-antagonisten zur behandlung von epstein- barr-virus-infektionen.
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked